Market Overview

10 Biggest Price Target Changes For Thursday

Share:
  • Buckingham Research raised the price target for KB Home (NYSE: KBH) from $27 to $30. KB Home shares closed at $23.53 on Wednesday.
  • Goldman Sachs lowered Ross Stores, Inc. (NASDAQ: ROST) price target from $102 to $91. Ross Stores shares closed at $102.40 on Wednesday.
  • Bank of America boosted the price target for Owens Corning (NYSE: OC) from $58 to $72. Owens Corning shares closed at $54.60 on Wednesday.
  • Goldman Sachs cut the price target for Nordstrom, Inc. (NYSE: JWN) from $37 to $30. Nordstrom shares closed at $32.20 on Wednesday.
  • BMO Capital raised the price target on AngloGold Ashanti Limited (NYSE: AU) from $16 to $21. AngloGold Ashanti shares closed at $17.72 on Wednesday.
  • KeyBanc boosted Cable One Inc (NYSE: CABO) price target from $1210 to $1316. Cable One shares closed at $1,110.49 on Wednesday.
  • Goldman Sachs lowered the price target for FactSet Research Systems Inc. (NYSE: FDS) from $256 to $246. FactSet Research shares closed at $289.33 on Wednesday.
  • JP Morgan raised the price target for Grifols, S.A. (NASDAQ: GRFS) from $21 to $22.5. Grifols shares closed at $19.90 on Wednesday.
  • UBS raised the price target for General Mills, Inc. (NYSE: GIS) from $48 to $52. General Mills shares closed at $51.31 on Wednesday.
  • KeyBanc raised the price target for Coupa Software Inc (NASDAQ: COUP) from $127 to $136. Coupa Software shares closed at $118.94 on Wednesday.

 

Posted-In: Price Target ChangesPrice Target Intraday Update Analyst Ratings

 

Related Articles (AU + CABO)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
IINDoughertyAssumes34.0
PNRJefferiesInitiates Coverage On
YYUBSUpgrades
ROKUOppenheimerMaintains155.0
IPHIBank of AmericaMaintains80.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Zogenix Secures FDA Approval For Resubmission Of Seizure Drug Application

ImmunoGen To Focus Operations On Mivetuximab Soravtansine Development